Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.

Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.


's stock had its "hold" rating reiterated by investment analysts at Jefferies Group in a report issued on Monday, Market Beat Ratings reports. They currently have a $97.00 price target on the biopharmaceutical company's stock, down from their prior price target of $100.00.



from Biotech News